Jason Bednar
Stock Analyst at Piper Sandler
(2.13)
# 2,860
Out of 5,180 analysts
202
Total ratings
37.58%
Success rate
-5.25%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRTS Alpha Tau Medical | Downgrades: Neutral | $5 | $6.55 | -23.66% | 6 | Mar 4, 2026 | |
| ICUI ICU Medical | Maintains: Overweight | $172 → $178 | $125.38 | +41.97% | 4 | Feb 20, 2026 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $113 → $106 | $68.64 | +54.43% | 15 | Feb 18, 2026 | |
| BDX Becton, Dickinson and Company | Reiterates: Neutral | $205 → $170 | $154.69 | +9.90% | 13 | Feb 10, 2026 | |
| NVST Envista Holdings | Reiterates: Neutral | $21 → $25 | $24.26 | +3.05% | 15 | Feb 6, 2026 | |
| ALGN Align Technology | Maintains: Overweight | $200 → $220 | $166.26 | +32.32% | 33 | Feb 5, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $91 → $94 | $68.77 | +36.69% | 2 | Jan 30, 2026 | |
| MDLN Medline | Initiates: Overweight | $50 | $42.62 | +17.32% | 1 | Jan 12, 2026 | |
| SHC Sotera Health Company | Upgrades: Overweight | $17 → $24 | $13.25 | +81.13% | 4 | Jan 9, 2026 | |
| COO The Cooper Companies | Reiterates: Overweight | $83 → $94 | $69.31 | +35.62% | 15 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $98 | $63.45 | +54.45% | 8 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $4 | $4.25 | -5.88% | 8 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $200 → $210 | $177.32 | +18.43% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $9 → $2.5 | $1.18 | +111.86% | 12 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $34 | $10.36 | +228.19% | 11 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $16 | $11.20 | +42.86% | 8 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $83 → $77 | $72.70 | +5.91% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $4.5 | $3.62 | +24.31% | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $260 → $265 | $219.38 | +20.79% | 9 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $6 | $2.29 | +162.01% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $20 | $0.67 | +2,874.86% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $452.78 | -17.84% | 4 | Jan 3, 2024 |
Alpha Tau Medical
Mar 4, 2026
Downgrades: Neutral
Price Target: $5
Current: $6.55
Upside: -23.66%
ICU Medical
Feb 20, 2026
Maintains: Overweight
Price Target: $172 → $178
Current: $125.38
Upside: +41.97%
Merit Medical Systems
Feb 18, 2026
Maintains: Overweight
Price Target: $113 → $106
Current: $68.64
Upside: +54.43%
Becton, Dickinson and Company
Feb 10, 2026
Reiterates: Neutral
Price Target: $205 → $170
Current: $154.69
Upside: +9.90%
Envista Holdings
Feb 6, 2026
Reiterates: Neutral
Price Target: $21 → $25
Current: $24.26
Upside: +3.05%
Align Technology
Feb 5, 2026
Maintains: Overweight
Price Target: $200 → $220
Current: $166.26
Upside: +32.32%
GE HealthCare Technologies
Jan 30, 2026
Maintains: Overweight
Price Target: $91 → $94
Current: $68.77
Upside: +36.69%
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $42.62
Upside: +17.32%
Sotera Health Company
Jan 9, 2026
Upgrades: Overweight
Price Target: $17 → $24
Current: $13.25
Upside: +81.13%
The Cooper Companies
Dec 5, 2025
Reiterates: Overweight
Price Target: $83 → $94
Current: $69.31
Upside: +35.62%
Nov 7, 2025
Maintains: Overweight
Price Target: $94 → $98
Current: $63.45
Upside: +54.45%
Aug 7, 2025
Maintains: Neutral
Price Target: $3.5 → $4
Current: $4.25
Upside: -5.88%
Aug 6, 2025
Maintains: Overweight
Price Target: $200 → $210
Current: $177.32
Upside: +18.43%
Jul 31, 2025
Downgrades: Neutral
Price Target: $9 → $2.5
Current: $1.18
Upside: +111.86%
Jun 27, 2025
Reiterates: Overweight
Price Target: $34
Current: $10.36
Upside: +228.19%
Apr 30, 2025
Maintains: Neutral
Price Target: $20 → $16
Current: $11.20
Upside: +42.86%
Apr 30, 2025
Maintains: Overweight
Price Target: $83 → $77
Current: $72.70
Upside: +5.91%
Mar 28, 2025
Maintains: Overweight
Price Target: $5 → $4.5
Current: $3.62
Upside: +24.31%
Feb 3, 2025
Maintains: Overweight
Price Target: $260 → $265
Current: $219.38
Upside: +20.79%
Nov 7, 2024
Maintains: Overweight
Price Target: $8 → $6
Current: $2.29
Upside: +162.01%
Aug 7, 2024
Maintains: Overweight
Price Target: $70 → $20
Current: $0.67
Upside: +2,874.86%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $452.78
Upside: -17.84%